Evation of High-Mobility Group Box 1 after Clinical Autologous Islet Transplantation and Its Inverse Correlation with Outcomes

Low Temperature Condition Prevents Hypoxia-Induced Islet Cell Damage and HMGB1 Release in a Mouse Model

(2012) Takeshi Itoh et al.   CELL TRANSPLANTATION

Correlation of Released HMGB1 Levels with the Degree of Islet Damage in Mice and Humans and with the Outcomes of Islet Transplantation in Mice

(2012) Takeshi Itoh et al.   CELL TRANSPLANTATION

Chronic pancreatitis

(2011) Joan M Braganza et al.   LANCET

High-Mobility Group Box 1 Expressions in Hypoxia-Induced Damaged Mouse Islets

(2011) T. Itoh et al.   TRANSPLANTATION PROCEEDINGS

Autologous islet cell transplantation to prevent surgical diabetes

(2011) Shinichi MATSUMOTO   Journal of Diabetes

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

Seven Consecutive Successful Clinical Islet Isolations with Pancreatic Ductal Injection

(2010) Shinichi Matsumoto et al.   CELL TRANSPLANTATION

Impact of serum high-mobility group box 1 protein elevation on oxygenation impairment after thoracic aortic aneurysm repair

(2010) Takashi Kohno et al.   HEART AND VESSELS

High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice

(2010) Nobuhide Matsuoka et al.   JOURNAL OF CLINICAL INVESTIGATION

Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis: Observations from the Dallas Heart Study

(2009) J. B. Lindsey et al.   DIABETES CARE

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

(2008) A. Soro-Paavonen et al.   DIABETES

The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage

(2008) S. Muhammad et al.   JOURNAL OF NEUROSCIENCE